Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page
- Check4 days agoChange DetectedAdds a recruitment-status note 'No longer looking for participants' to the study history, indicating enrollment is no longer active. The history also introduces the revision tag v3.6.0 and removes the older revision tag v3.5.5, updating the record's version history.SummaryDifference0.3%

- Check11 days agoChange DetectedThe history now includes a new revision entry (v3.5.5) and removes the prior revision (v3.5.4), reflecting an update to the page’s version history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision label, v3.5.4, has been added to the page, replacing the previous v3.5.3. This change updates the page's revision history metadata.SummaryDifference0.1%

- Check54 days agoChange DetectedThe change reflects an update to the ClinicalTrials.gov record history page/versioning and revision label rather than substantive changes to the study information itself.SummaryDifference0.5%

- Check61 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3 in the Record History page.SummaryDifference0.1%

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.